In the case of OAS pathways, such mechanistic understanding is crucial, as introgressed variants linked to the expression of OAS1-2-3, including one emVar identified in the MPRA, have been found to be somewhat protective against severe COVID-19 response (Zeberg and Pääbo 2020b). The gene discussed is SMOC1; the disease is COVID-19.